)
Business philosophy23 Apr 2026
Greg Foran: The New CEO of Kroger
How Greg Foran rose from store floor to CEO of Kroger, led Walmart's turnaround, and built a leadership style focused on execution.
Sarepta Therapeutics
Sarepta Therapeutics (SRPT) investor relations material
Sarepta Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary24 Apr, 2026
Executive summary
Annual meeting scheduled for June 4, 2026, to be held virtually at 10:00 AM EDT.
Proxy materials and annual report are available online for review and voting.
Shareholders are encouraged to vote online or request paper copies of materials by May 26, 2026.
Voting matters and shareholder proposals
Election of five Class I director nominees to serve until the 2028 annual meeting.
Advisory vote on executive officer compensation (say-on-pay) on a non-binding basis.
Approval of the 2026 Equity Incentive Plan.
Approval of the 2026 Employee Stock Purchase Plan.
Ratification of KPMG LLP as independent registered public accounting firm for the year ending December 31, 2026.
Board of directors and corporate governance
Board recommends voting "FOR" all director nominees and all proposals listed.
Director nominees include Douglas S. Ingram, Hans Wigzell, Kathryn J. Boor, Michael Chambers, and Deirdre Connelly.
Identify the five Class I director nominees
Identify the 2026 equity and stock purchase plans
Specify the 2026 advisory vote on executive pay
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sarepta Therapeutics
- Proxy seeks approval for director elections, compensation, equity plans, and auditor ratification.SRPT
Proxy filing24 Apr 2026 - 2026 outlook: $954M cash, $1.2–$1.4B revenue guidance, stable franchises, Japan launch.SRPTQ4 202512 Apr 2026
- SRP-1001 and SRP-1003 show strong early efficacy, safety, and muscle delivery, with phase III trials planned for 2027.SRPTStudy result25 Mar 2026
- 2026 revenue targets remain solid as clinical and commercial initiatives advance toward 2027.SRPTTD Cowen 46th Annual Health Care Conference3 Mar 2026
- Two-year results confirm durable efficacy, safety, and muscle health benefits in Duchenne.SRPTStatus Update3 Feb 2026
- FDA expands ELEVIDYS approval for Duchenne patients 4+, with robust readiness and stable pricing.SRPTStatus Update3 Feb 2026
- Three-year data show ELEVIDYS provides durable, significant slowing of Duchenne progression.SRPTStudy result2 Feb 2026
- Q2 2024 revenue up 51% to $362.9M, led by ELEVIDYS; 2025 guidance $2.9–$3.1B.SRPTQ2 20242 Feb 2026
- All proposals, including director elections and auditor ratification, were approved.SRPTAGM 20241 Feb 2026
Next Sarepta Therapeutics earnings date
Q1 20266 May, 2026
Sarepta Therapeutics
Next Sarepta Therapeutics earnings date
Q1 20266 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
)
Business philosophy22 Apr 2026
Benedetto Vigna: The CEO of Ferrari
An unexpected leader for Ferrari: how semiconductor expert Benedetto Vigna became CEO and why his background fits the industry's shift.
Frequently asked questions
Explore our global coverage